We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+7.83%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$104B
AUM Growth
-$8.26B
Cap. Flow
-$18.3B
Cap. Flow %
-17.65%
Top 10 Hldgs %
9.93%
Holding
4,712
New
825
Increased
1,119
Reduced
1,773
Closed
730

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$862M
2
BIDU icon
Baidu
BIDU
+$752M
3
TME icon
Tencent Music
TME
+$426M
4
KO icon
Coca-Cola
KO
+$424M
5
NVDA icon
NVIDIA
NVDA
+$383M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$981M
2
WFC icon
Wells Fargo
WFC
+$673M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$574M
4
MRNA icon
Moderna
MRNA
+$442M
5
DD icon
DuPont de Nemours
DD
+$415M

Sector Composition

Rank Sector Weight
1 Technology 16.45%
2 Consumer Discretionary 10.49%
3 Communication Services 9.04%
4 Healthcare 8.89%
5 Financials 6.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CALA
3826
DELISTED
Calithera Biosciences, Inc
CALA
$51K ﹤0.01%
1,056
-1,853
-64% -$108K
SCPE.WS
3827
DELISTED
SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an
SCPE.WS
$51K ﹤0.01%
26,863
-85,637
-76% -$139K
IVR icon
3828
Invesco Mortgage Capital
IVR
$805M
$50K ﹤0.01%
1,251
-2,662
-68% -$100K
SWBK.WS
3829
DELISTED
Switchback II Corporation Warrants, exercisable for one share of Class A Ordinary Share
SWBK.WS
$50K ﹤0.01%
+25,000
New +$58.4K
PVLA
3830
Palvella Therapeutics
PVLA
$2.1B
$49K ﹤0.01%
+239
New +$52.2K
ABEV icon
3831
Ambev
ABEV
$45B
$48K ﹤0.01%
17,565
-11,396
-39% -$32.2K
OGI
3832
Organigram Holdings
OGI
$178M
$46K ﹤0.01%
+3,325
New +$38.4K
ASAP
3833
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$40K ﹤0.01%
685
ARC
3834
DELISTED
ARC Document Solutions, Inc.
ARC
$35K ﹤0.01%
16,803
-69,411
-81% -$147K
GOEVW
3835
DELISTED
Canoo Inc. Warrant
GOEVW
$34K ﹤0.01%
11,872
TINV.WS
3836
DELISTED
Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TINV.WS
$33K ﹤0.01%
+25,446
New +$47.1K
TH icon
3837
Target Hospitality
TH
$1.78B
$31K ﹤0.01%
12,227
-153,492
-93% -$284K
AGCWW
3838
DELISTED
Altimeter Growth Corp Warrant
AGCWW
$31K ﹤0.01%
+10,000
New +$45.4K
CCAC.WS
3839
DELISTED
CITIC Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary sh
CCAC.WS
$28K ﹤0.01%
25,000
GAU
3840
Galiano Gold
GAU
$633M
$26K ﹤0.01%
+23,655
New +$28.2K
TYME
3841
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$23K ﹤0.01%
+13,158
New +$27.3K
PV.WS
3842
DELISTED
Primavera Capital Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PV.WS
$21K ﹤0.01%
+25,000
New +$26.4K
RTPZ.WS
3843
DELISTED
Reinvent Technology Partners Z Redeemable warrants, each whole warrant exercisable for one Class A o
RTPZ.WS
$16K ﹤0.01%
+10,000
New +$28.8K
PTE
3844
DELISTED
PolarityTE, Inc. Common Stock
PTE
$11K ﹤0.01%
406
-21,096
-98% -$653K
AAOI icon
3845
CALL
Applied Optoelectronics
AAOI
$9.1B
-20,000
Closed -$170K
AAOI icon
3846
PUT
Applied Optoelectronics
AAOI
$9.1B
-40,000
Closed -$340K
AAP icon
3847
PUT
Advance Auto Parts
AAP
$2.63B
-75,500
Closed -$11.9M
ABEO icon
3848
Abeona Therapeutics
ABEO
$347M
-3,331
Closed -$131K
ABR icon
3849
CALL
Arbor Realty Trust
ABR
$979M
-50,000
Closed -$709K
ACB
3850
Aurora Cannabis
ACB
$249M
-1,564
Closed -$175K

Similar funds

David Shaw's Q1 2021 Portfolio in Review

As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, David Shaw opened a new position in Baidu worth $627M.

  • David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
  • David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
  • David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
  • David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
  • David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
  • David Shaw opened 825 new positions and closed 730 in Q1 2021.
  • David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.

Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.